University of California San Francisco
Give to UCSF
Presentation by Ambassador Stephen Lewis, co-director, AIDS-Free World and U.N. special envoy for HIV/AIDS in Africa (2001-2006), follow by panel discussion and reception. Lewis will be introduced by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH.
The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.
Actress Kathleen Turner will visit the research labs of the Rosalind Russell Arthritis Center at UCSF to gain a better understanding of the impact of autoimmune diseases and to learn firsthand about ongoing UCSF research for potential therapies.
A collaboration between scientists at Vanderbilt University and the University of California, San Francisco has led to the first direct information about the molecular structure of prions. In addition, the study has revealed surprisingly large structural differences between natural prions and the closest synthetic analogs that scientists have created in the lab.
Molecular biologist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco, today was named to receive the 2009 Nobel Prize in Physiology or Medicine.
Scientist Elizabeth H. Blackburn, PhD, 60, of the University of California, San Francisco was named today (Oct. 5, 2009) to receive the 2009 Nobel Prize in Physiology or Medicine.
UCSF's Elizabeth Blackburn, PhD, addressed the media during a news conference at the Mission Bay campus on Oct. 5, held in recognition of the announcement that she received the 2009 Nobel Prize in Physiology or Medicine
Opening today at Mission Bay, the UCSF Orthopaedic Institute is a major new center that is the most comprehensive location in the Bay Area for outpatient treatment, research and training in musculoskeletal conditions, injuries and sports medicine.
Kick-off event for the 20th annual Macy’s Christmas Tree Lighting benefiting UCSF Children’s Hospital. The celebration will feature a visit from Honorary Chair and San Francisco Giants pitcher Barry Zito, as well as face painting, refreshments, and elves to entertain young patients. Great photo, audio and video opportunities.
Territorial behavior in male mice might be linked to more “girl-power” than ever suspected, according to new findings at UCSF. For the first time, researchers have identified networks of nerve cells in the brain that are associated with how male mice defend their territory and have shown that these cells are controlled by the female hormone estrogen.
In a study of nearly 250,000 veterans of the wars in Iraq and Afghanistan, those who were diagnosed with mental health disorders used non-mental health medical services provided by the Department of Veterans Affairs at significantly higher rates than those without mental health disorders.
UCSF is celebrating the grand opening of its new Orthopaedic Institute, a major new facility for treating patients and translational research.
Researchers at UCSF Medical Center have begun enrollment for an early-stage clinical trial to evaluate the safety and efficacy of an adult stem cell therapy for patients who have just experienced their first acute myocardial infarction, or heart attack. The trial is part of a multi-center national study.
The nation’s only clinical trial matching service dedicated exclusively to breast cancer—BreastCancerTrials.org—is now upgraded with new features, greatly expanding access and ensuring privacy for all who want the latest information about research studies and how to enroll. Cancer patients, survivors and those who are at risk now have a free, easy-to-use resource that custom matches them to clinical trials specifically targeted to their personal health profiles. BreastCancerTrials.org empowers patients with knowledge, opens the door to hope and paves the way for future cures.
The University of California is launching an unprecedented statewide collaboration for breast cancer patients with the goal of revolutionizing the course of their care by designing and testing new approaches to research, technology and health care delivery.
Screening all newborns for excessive bilirubin in the blood can significantly decrease the incidence of severe jaundice which, in extreme cases, can lead to seizures and brain damage, according to researchers at UCSF Children’s Hospital and Kaiser Permanente’s Division of Research in Oakland, CA.
Seven UCSF scientists have received research awards from the National Institutes of Health under an initiative designed to encourage innovative, risk-taking investigations.
Private cord blood banking is not cost-effective because it costs an additional $1,374,246 per life-year gained, according to a new analysis by UCSF researchers. The research team also concluded that private cord blood banking is cost-effective only for families with a child with a very high likelihood of needing a stem cell transplant.
The University of California, San Francisco has named Sam Hawgood, MBBS, as dean of the UCSF School of Medicine and vice chancellor for medical affairs. The appointment was reported today to the UC Board of Regents. It is effective immediately.
A new way to select and switch on one cell type in an organism using light has helped answer a long-standing question about the function of one class of enigmatic nerve cells in the spinal cord.
People in pain have the same degree of functional limitation as people who are pain-free but two to three decades older, according to a study of more than 18,000 older Americans led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
UCSF and the National Association For Continence (NAFC) are holding a public workshop on October 3 to help women understand how they can control and treat incontinence. Even though urinary incontinence can be improved in eight out of 10 cases, fewer than half of those with bladder problems ever talk about the condition with their health care professionals, according to the Agency for Healthcare Quality and Research.
UCSF researchers have identified collections of tiny molecules known as microRNAs that affect distinct processes critical for the progression of cancer. The findings, they say, expand researchers’ understanding of the important regulatory function of microRNAs in tumor biology and point to new directions for future study and potential treatments.
Shinya Yamanaka, MD, PhD, of the UCSF-affiliated Gladstone Institute of Cardiovascular Disease and Kyoto University, has won the 2009 Albert Lasker Basic Medical Research Award for his discovery of a method of reprogramming adult skin cells to become embryonic-like stem cells. Yamanaka, who is the L.K. Whittier Investigator in Stem Cell Biology at Gladstone and professor of anatomy at UCSF, is one of the youngest recipients of the award, which is one of the highest scientific honors bestowed in the United States.
UCSF researchers have genetically encoded mouse cells to respond to light, creating cells that can be trained to follow a light beam or stop on command like microscopic robots.
UCSF researchers are set to begin a Phase I clinical trial in collaboration with StemCells, Inc. to test the safety and preliminary effectiveness of using neural stem cells to treat children with a rare, fatal form of a brain disorder known as Pelizaeus-Merzbacher disease (PMD). Currently, there are no effective treatments for the fatal forms of the disease, which affects males that inherit a single defective gene.
UCSF leaders, a patient advocate who is a member of the board of the California Institute for Regenerative Medicine and construction workers will gather for a “topping off” ceremony to celebrate the placement of the last structural steel beam on the building that will be the headquarters for The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF.
Scientists have discovered that deer asymptomatic for a fatal brain condition known as chronic wasting disease excrete the infectious prions that cause the disease in their feces. The finding, they say, suggests a plausible explanation for transmission of the disease among deer and, possibly, elk and moose in the environment.
UCSF researchers have successfully used protease inhibitors to restore to normal levels a key protein involved in early brain development. Reduced levels of that protein have been shown to cause the rare brain disorder lissencephaly, which is characterized by brain malformations, seizures, severe mental retardation and very early death in human infants.